Loading clinical trials...
Loading clinical trials...
To demonstrate statistical superiority of the combination of latanoprost and timolol to the individual therapy of latanoprost and timolol based on intraocular pressure measurements at 8 AM, 10 AM, 4 P...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
NCT07396441 · Juvenile Open Angle Glaucoma, Dry Eye Disease (DED), and more
NCT07390890 · Primary Open Angle Glaucoma, Ocular Hypertension
NCT07358650 · Primary Open Angle Glaucoma
NCT05902871 · Primary Open Angle Glaucoma, Ocular Hypertension, and more
NCT07218796 · Cataract, Glaucoma, and more
Pfizer Investigational Site
Birmingham, Alabama
Pfizer Investigational Site
Flagstaff, Arizona
Pfizer Investigational Site
Artesia, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions